Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Synopsys, Inc. (NASDAQ: SNPS) closed at $519.71 in the last session, down -1.49% from day before closing price of $527.58. In other words, the price has decreased by -$1.49 from its previous closing price. On the day, 1.18 million shares were traded. SNPS stock price reached its highest trading level at $530.0 during the session, while it also had its lowest trading level at $517.06.
Ratios:
We take a closer look at SNPS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 62.18 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 60.32. For the most recent quarter (mrq), Quick Ratio is recorded 1.14 and its Current Ratio is at 1.29. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on April 04, 2024, initiated with a Overweight rating and assigned the stock a target price of $665.
On November 30, 2023, Needham reiterated its Buy rating and also lowered its target price recommendation from $500 to $660.
On November 10, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $600.Morgan Stanley initiated its Overweight rating on November 10, 2023, with a $600 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 03 ’24 when RUNKEL JOHN F JR sold 5,319 shares for $579.37 per share. The transaction valued at 3,081,663 led to the insider holds 20,000 shares of the business.
CASPER MARC N bought 750 shares of SNPS for $439,087 on Mar 25 ’24. The Director now owns 1,736 shares after completing the transaction at $585.45 per share. On Feb 27 ’24, another insider, VALLEE ROY, who serves as the Director of the company, sold 10,000 shares for $572.66 each. As a result, the insider received 5,726,595 and left with 20,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNPS now has a Market Capitalization of 79278645248 and an Enterprise Value of 78710636544. As of this moment, Synopsys,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 57.24, and their Forward P/E ratio for the next fiscal year is 33.59. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.91 while its Price-to-Book (P/B) ratio in mrq is 11.88. Its current Enterprise Value per Revenue stands at 12.839 whereas that against EBITDA is 49.685.
Stock Price History:
Over the past 52 weeks, SNPS has reached a high of $629.38, while it has fallen to a 52-week low of $360.36. The 50-Day Moving Average of the stock is -8.57%, while the 200-Day Moving Average is calculated to be 2.62%.
Shares Statistics:
According to the various share statistics, SNPS traded on average about 1.17M shares per day over the past 3-months and 906090 shares per day over the past 10 days. A total of 152.05M shares are outstanding, with a floating share count of 151.90M. Insiders hold about 0.42% of the company’s shares, while institutions hold 88.04% stake in the company. Shares short for SNPS as of 1711584000 were 3439195 with a Short Ratio of 2.95, compared to 1709164800 on 3206447. Therefore, it implies a Short% of Shares Outstanding of 3439195 and a Short% of Float of 2.26.
Earnings Estimates
The market rating for Synopsys, Inc. (SNPS) is a result of the insights provided by Synopsys, Inc. analysts actively involved in the assessment.The consensus estimate for the next quarter is $30.17, with high estimates of $10.58 and low estimates of $25.20.
